Company registration number: 15665818
Unaudited financial statements
for the period ended 30 April 2025
for
Siftr Bio Limited
Pages for filing with the Registrar
Company registration number: 15665818
Siftr Bio Limited
Balance sheet
as at 30 April 2025
£ £
Fixed assets 44,950
Current assets 785,062
Creditors: amounts falling due within one year (7,584)
Net current assets 777,478
NET ASSETS 822,428
CAPITAL AND RESERVES 822,428
Notes
1 Company information
Siftr Bio Limited is a private company registered in England and Wales. Its registered number is 15665818. The company is limited by shares. Its registered office is White City Incubator Scalespace, 58 Wood Lane, London, W12 7RZ.
2 Off-balance sheet arrangements
The company had no off-balance sheet arrangements at year-end or at any stage during the period.
3 Average number of employees
During the period the average number of employees was 2.
4 Advances, credit and guarantees granted to directors
There were no advances, credits and guarantees granted to the directors during the period.
5 Guarantees and other financial commitments
There were no financial guarantees or commitments, either ongoing or entered into during the period.
6 Statement of Going Concern
In preparing the annual accounts the directors confirm that they believe the company can continue as a
going concern for at least the next 12 months from the date of these accounts. The Directors have
confirmed their intention to support the continued operation of the business.
The company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies for the period ended 30 April 2025.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
1
Company registration number: 15665818
Siftr Bio Limited
Balance sheet - continued
as at 30 April 2025
The directors acknowledge their responsibilities to comply with the Companies Act 2006 in respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the micro-entity provisions.
The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the Board of directors and authorised for issue on 12 December 2025 and signed on its behalf by:
Dr D Lucy, Director
12 December 2025
2